{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:06:25Z","timestamp":1757628385102,"version":"3.44.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 24K12281"],"award-info":[{"award-number":["JP 24K12281"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s11060-025-05172-0","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:24:05Z","timestamp":1753100645000},"page":"753-762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hemagglutinating virus of Japan envelope encapsulating microRNA-34a-5p robustly induces apoptosis of malignant meningioma cells by suppressing survivin"],"prefix":"10.1007","volume":"175","author":[{"given":"Takaaki","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasufumi","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"5172_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","volume":"25","author":"QT Ostrom","year":"2023","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2023) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2016\u20132020. Neuro Oncol 25:iv1\u2013iv99. https:\/\/doi.org\/10.1093\/neuonc\/noad149","journal-title":"Neuro Oncol"},{"key":"5172_CR2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ijrobp.2011.08.010","volume":"83","author":"S Adeberg","year":"2012","unstructured":"Adeberg S, Hartmann C, Welzel T, Rieken S, Habermehl D, von Deimling A, Debus J, Combs SE (2012) Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas\u2013clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. Int J Radiat Oncol Biol Phys 83:859\u2013864. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.08.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5172_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11060-009-9948-7","volume":"96","author":"AD Norden","year":"2010","unstructured":"Norden AD, Raizer JJ, Abrey LE, Lamborn KR, Lassman AB, Chang SM, Yung WK, Gilbert MR, Fine HA, Mehta M, Deangelis LM, Cloughesy TF, Robins HI, Aldape K, Dancey J, Prados MD, Lieberman F, Wen PY (2010) Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. J Neurooncol 96:211\u2013217. https:\/\/doi.org\/10.1007\/s11060-009-9948-7","journal-title":"J Neurooncol"},{"key":"5172_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11060-012-0886-4","volume":"109","author":"L Nayak","year":"2012","unstructured":"Nayak L, Iwamoto FM, Rudnick JD, Norden AD, Lee EQ, Drappatz J, Omuro A, Kaley TJ (2012) Atypical and anaplastic meningiomas treated with bevacizumab. J Neurooncol 109:187\u2013193. https:\/\/doi.org\/10.1007\/s11060-012-0886-4","journal-title":"J Neurooncol"},{"key":"5172_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/1078-0432.CCR-19-2109","volume":"26","author":"T Graillon","year":"2020","unstructured":"Graillon T, Sanson M, Campello C, Idbaih A, Peyre M, Peyriere H, Basset N, Autran D, Roche C, Kalamarides M, Roche PH, Fuentes S, Tabouret E, Barrie M, Cohen A, Honore S, Boucekine M, Baumstarck K, Figarella-Branger D, Barlier A, Dufour H, Chinot OL (2020) Everolimus and octreotide for patients with recurrent meningioma: results from the phase II CEVOREM trial. Clin Cancer Res 26:552\u2013557. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2109","journal-title":"Clin Cancer Res"},{"key":"5172_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12885-022-09340-7","volume":"22","author":"K Belanger","year":"2022","unstructured":"Belanger K, Ung TH, Damek D, Lillehei KO, Ormond DR (2022) Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review. BMC Cancer 22:367. https:\/\/doi.org\/10.1186\/s12885-022-09340-7","journal-title":"BMC Cancer"},{"key":"5172_CR7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, \u00d6zduman K, Av\u015far T, Li J, Murray PB, Henegariu O, Yilmaz S, G\u00fcnel JM, Carri\u00f3n-Grant G, Y\u0131lmaz B, Grady C, Tanr\u0131kulu B, Bak\u0131rc\u0131o\u011flu M, Kaymak\u00e7alan H, Caglayan AO, Sencar L, Ceyhun E, Atik AF, Bayri Y, Bai H, Kolb LE, Hebert RM, Omay SB, Mishra-Gorur K, Choi M, Overton JD, Holland EC, Mane S, State MW, Bilg\u00fcvar K, Baehring JM, Gutin PH, Piepmeier JM, Vortmeyer A, Brennan CW, Pamir MN, K\u0131l\u0131\u00e7 T, Lifton RP, Noonan JP, Yasuno K, G\u00fcnel M (2013) Genomic analysis of non-NF2 meningiomas reveals mutaions in TRAF7, KLF4, AKT1, and SMO. Science 339:1077\u20131080. https:\/\/doi.org\/10.1126\/science.1233009","journal-title":"Science"},{"key":"5172_CR8","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ng.3651","volume":"48","author":"VE Clark","year":"2016","unstructured":"Clark VE, Harmanci AS, Bai H, Youngblood MW, Lee TI, Baranoski JF, Ercan-Sencicek AG, Abraham BJ, Weintraub AS, Hnisz D, Simon M, Krischek B, Erson-Omay EZ, Henegariu O, Carrion-Grant G, Mishra-Gorur K, Duran D, Goldmann JE, Schramm J, Goldbrunner R, Piepmeier JM, Vortmeyer AO, Gunel JM, Bilguvar K, Yasuno K, Young RA, Gunel M (2016) Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet 48:1253\u20131259. https:\/\/doi.org\/10.1038\/ng.3651","journal-title":"Nat Genet"},{"key":"5172_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2176\/jns-nmc.2022-0114","volume":"62","author":"A Okano","year":"2022","unstructured":"Okano A, Miyawaki S, Teranishi Y, Ohara K, Hongo H, Sakai Y, Ishigami D, Nakatomi H, Saito N (2022) Advances in molecular biological and translational studies in world health organization grades 2 and 3 meningiomas: A literature review. Neurologia medico-chirurgica 62:347\u2013360. https:\/\/doi.org\/10.2176\/jns-nmc.2022-0114","journal-title":"Neurologia medico-chirurgica"},{"key":"5172_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1006\/mthe.2002.0647","volume":"6","author":"Y Kaneda","year":"2002","unstructured":"Kaneda Y, Nakajima T, Nishikawa T, Yamamoto S, Ikegami H, Suzuki N, Nakamura H, Morishita R, Kotani H (2002) Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther 6:219\u2013226. https:\/\/doi.org\/10.1006\/mthe.2002.0647","journal-title":"Mol Ther"},{"key":"5172_CR11","doi-asserted-by":"publisher","first-page":"113834","DOI":"10.1016\/j.addr.2021.113834","volume":"178","author":"A Gupta","year":"2021","unstructured":"Gupta A, Andresen JL, Manan RS, Langer R (2021) Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev 178:113834. https:\/\/doi.org\/10.1016\/j.addr.2021.113834","journal-title":"Adv Drug Deliv Rev"},{"key":"5172_CR12","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1002\/ijc.24234","volume":"124","author":"Y Kawaguchi","year":"2009","unstructured":"Kawaguchi Y, Miyamoto Y, Inoue T, Kaneda Y (2009) Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle. Int J Cancer 124:2478\u20132487. https:\/\/doi.org\/10.1002\/ijc.24234","journal-title":"Int J Cancer"},{"key":"5172_CR13","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.1158\/1078-0432.CCR-12-1595","volume":"18","author":"T Matsushima-Miyagi","year":"2012","unstructured":"Matsushima-Miyagi T, Hatano K, Nomura M, Li-Wen L, Nishikawa T, Saga K, Shimbo T, Kaneda Y (2012) TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I\/MAVS signaling pathway by nonreplicating Sendai virus particles. Clin Cancer Res 18:6271\u20136283. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1595","journal-title":"Clin Cancer Res"},{"key":"5172_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/cbr.2014.1704","volume":"30","author":"LY Shi","year":"2015","unstructured":"Shi LY, Han Z, Li XX, Li M, Han H, Chen J, Zang S (2015) Inactivated Sendai virus strain Tianjin induces apoptosis in breast cancer MCF-7 cells by promoting caspase activation and fas\/fasl expression. Cancer Biother Radiopharm 30:33\u201340. https:\/\/doi.org\/10.1089\/cbr.2014.1704","journal-title":"Cancer Biother Radiopharm"},{"key":"5172_CR15","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/jgm.753","volume":"7","author":"M Ito","year":"2005","unstructured":"Ito M, Yamamoto S, Nimura K, Hiraoka K, Tamai K, Kaneda Y (2005) Rad51 SiRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin. J Gene Med 7:1044\u20131052. https:\/\/doi.org\/10.1002\/jgm.753","journal-title":"J Gene Med"},{"key":"5172_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/gt.2011.123","volume":"19","author":"E Kiyohara","year":"2012","unstructured":"Kiyohara E, Tamai K, Katayama I, Kaneda Y (2012) The combination of chemotherapy with HVJ-E containing Rad51 SiRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma. Gene Ther 19:734\u2013741. https:\/\/doi.org\/10.1038\/gt.2011.123","journal-title":"Gene Ther"},{"key":"5172_CR17","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/gt.2009.99","volume":"16","author":"M Matsuda","year":"2009","unstructured":"Matsuda M, Yamamoto T, Matsumura A, Kaneda Y (2009) Highly efficient eradication of intracranial glioblastoma using Eg5 SiRNA combined with HVJ envelope. Gene Ther 16:1465\u20131476. https:\/\/doi.org\/10.1038\/gt.2009.99","journal-title":"Gene Ther"},{"key":"5172_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11060-010-0355-x","volume":"103","author":"M Matsuda","year":"2011","unstructured":"Matsuda M, Nimura K, Shimbo T, Hamasaki T, Yamamoto T, Matsumura A, Kaneda Y (2011) Immunogene therapy using Immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma. J Neurooncol 103:19\u201331. https:\/\/doi.org\/10.1007\/s11060-010-0355-x","journal-title":"J Neurooncol"},{"key":"5172_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/cas.14721","volume":"112","author":"N Sugii","year":"2021","unstructured":"Sugii N, Matsuda M, Okumura G, Shibuya A, Ishikawa E, Kaneda Y, Matsumura A (2021) Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 SiRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma. Cancer Sci 112:81\u201390. https:\/\/doi.org\/10.1111\/cas.14721","journal-title":"Cancer Sci"},{"key":"5172_CR20","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu TX, Rothenberg ME (2018) MicroRNA. J Allergy Clin Immunol 141:1202\u20131207. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.034","journal-title":"J Allergy Clin Immunol"},{"key":"5172_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/neuros\/nyaa009","volume":"87","author":"H Slavik","year":"2020","unstructured":"Slavik H, Balik V, Vrbkova J, Rehulkova A, Vaverka M, Hrabalek L, Ehrmann J, Vidlarova M, Gurska S, Hajduch M, Srovnal J (2020) Identification of meningioma patients at high risk of tumor recurrence using MicroRNA profiling. Neurosurgery 87:1055\u20131063. https:\/\/doi.org\/10.1093\/neuros\/nyaa009","journal-title":"Neurosurgery"},{"key":"5172_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fonc.2020.00501","volume":"10","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang G, Huang H, Li H, Lin S, Wang Y (2020) Differentially expressed MicroRNAs in radioresistant and radiosensitive atypical meningioma: A clinical study in Chinese patients. Front Oncol 10:501. https:\/\/doi.org\/10.3389\/fonc.2020.00501","journal-title":"Front Oncol"},{"key":"5172_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s10555-021-09973-3","volume":"40","author":"S Li","year":"2021","unstructured":"Li S, Wei X, He J, Cao Q, Du D, Zhan X, Zeng Y, Yuan S, Sun L (2021) The comprehensive landscape of miR-34a in cancer research. Cancer Metastasis Rev 40:925\u2013948. https:\/\/doi.org\/10.1007\/s10555-021-09973-3","journal-title":"Cancer Metastasis Rev"},{"key":"5172_CR24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.18632\/aging.101201","volume":"9","author":"TV Werner","year":"2017","unstructured":"Werner TV (2017) MiR-34a-3p alters proliferation and apoptosis of meningioma cells in vitro and is directly targeting SMAD4, FRAT1 and BCL2. Aging 9:932\u2013954. https:\/\/doi.org\/10.18632\/aging.101201","journal-title":"Aging"},{"key":"5172_CR25","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/sj.gt.3302280","volume":"11","author":"L Yang","year":"2004","unstructured":"Yang L, Cao Z, Li F, Post DE, Van Meir EG, Zhong H, Wood WC (2004) Tumor-specific gene expression using the survivin promoter is further increased by hypoxia. Gene Ther 11:1215\u20131223. https:\/\/doi.org\/10.1038\/sj.gt.3302280","journal-title":"Gene Ther"},{"key":"5172_CR26","doi-asserted-by":"publisher","first-page":"109141","DOI":"10.1016\/j.jneumeth.2021.109141","volume":"356","author":"N Waldt","year":"2021","unstructured":"Waldt N, Kesseler C, Fala P, John P, Kirches E, Angenstein F, Mawrin C (2021) Crispr\/Cas-based modeling of NF2 loss in meningioma cells. J Neurosci Methods 356:109141. https:\/\/doi.org\/10.1016\/j.jneumeth.2021.109141","journal-title":"J Neurosci Methods"},{"key":"5172_CR27","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1016\/j.celrep.2018.03.013","volume":"22","author":"HN Vasudevan","year":"2018","unstructured":"Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY, Nicholaides T, Chang SM, Sneed PK, McDermott MW, Berger MS, Perry A, Raleigh DR (2018) Comprehensive molecular profiling identifies FOXM1 as a key transcription factor for meningioma proliferation. Cell Rep 22:3672\u20133683. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.013","journal-title":"Cell Rep"},{"key":"5172_CR28","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1093\/neuonc\/noab155","volume":"23","author":"S Yamazaki","year":"2021","unstructured":"Yamazaki S, Ohka F, Hirano M, Shiraki Y, Motomura K, Tanahashi K, Tsujiuchi T, Motomura A, Aoki K, Shinjo K, Murofushi Y, Kitano Y, Maeda S, Kato A, Shimizu H, Yamaguchi J, Adilijiang A, Wakabayashi T, Saito R, Enomoto A, Kondo Y, Natsume A (2021) Newly established patient-derived organoid model of intracranial meningioma. Neurooncology 23:1936\u20131948. https:\/\/doi.org\/10.1093\/neuonc\/noab155","journal-title":"Neurooncology"},{"key":"5172_CR29","doi-asserted-by":"publisher","first-page":"14433","DOI":"10.1038\/ncomms14433","volume":"8","author":"AS Harmanci","year":"2017","unstructured":"Harmanci AS, Youngblood MW, Clark VE, Coskun S, Henegariu O, Duran D, Erson-Omay EZ, Kaulen LD, Lee TI, Abraham BJ, Simon M, Krischek B, Timmer M, Goldbrunner R, Omay SB, Baranoski J, Baran B, Carrion-Grant G, Bai H, Mishra-Gorur K, Schramm J, Moliterno J, Vortmeyer AO, Bilguvar K, Yasuno K, Young RA, Gunel M (2017) Integrated genomic analyses of de Novo pathways underlying atypical meningiomas. Nat Commun 8:14433. https:\/\/doi.org\/10.1038\/ncomms14433","journal-title":"Nat Commun"},{"key":"5172_CR30","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/cas.15221","volume":"113","author":"T Nakano","year":"2022","unstructured":"Nakano T, Fujimoto K, Tomiyama A, Takahashi M, Achiha T, Arita H, Kawauchi D, Yasukawa M, Masutomi K, Kondo A, Narita Y, Maehara T, Ichimura K (2022) Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma. Cancer Sci 113:697\u2013708. https:\/\/doi.org\/10.1111\/cas.15221","journal-title":"Cancer Sci"},{"key":"5172_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling PA-O, Brat DA-O, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"5172_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3892\/mmr.2016.5255","volume":"14","author":"J Duan","year":"2016","unstructured":"Duan J, Zhou K, Tang X, Duan J, Zhao L (2016) MicroRNA-34a inhibits cell proliferation and induces cell apoptosis of glioma cells via targeting of Bcl-2. Mol Med Rep 14:432\u2013438. https:\/\/doi.org\/10.3892\/mmr.2016.5255","journal-title":"Mol Med Rep"},{"key":"5172_CR33","doi-asserted-by":"publisher","first-page":"11579","DOI":"10.2147\/OTT.S228513","volume":"12","author":"SA Hu","year":"2019","unstructured":"Hu SA, Wei W, Yuan J, Cheng J (2019) Resveratrol inhibits proliferation in HBL-52 meningioma cells. Onco Targets Ther 12:11579\u201311586. https:\/\/doi.org\/10.2147\/OTT.S228513","journal-title":"Onco Targets Ther"},{"key":"5172_CR34","doi-asserted-by":"publisher","first-page":"640587","DOI":"10.3389\/fcell.2021.640587","volume":"9","author":"WJ Li","year":"2021","unstructured":"Li WJ, Wang Y, Liu R, Kasinski AL, Shen H, Slack FJ, Tang DG (2021) MicroRNA-34a: potent tumor suppressor, Cancer stem cell inhibitor, and potential anticancer therapeutic. Front Cell Dev Biol 9:640587. https:\/\/doi.org\/10.3389\/fcell.2021.640587","journal-title":"Front Cell Dev Biol"},{"key":"5172_CR35","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1007\/s12032-011-0156-x","volume":"29","author":"Z Shen","year":"2012","unstructured":"Shen Z, Zhan G, Ye D, Ren Y, Cheng L, Wu Z, Guo J (2012) MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin. Med Oncol 29:2473\u20132480. https:\/\/doi.org\/10.1007\/s12032-011-0156-x","journal-title":"Med Oncol"},{"key":"5172_CR36","unstructured":"TargetScanHuman TargetScan Prediction of microRNA targets. https:\/\/www.targetscan.org\/vert_80\/. Accessed 3 Dec 2023"},{"key":"5172_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2147\/OV.S66419","volume":"4","author":"K Saga","year":"2015","unstructured":"Saga K, Kaneda Y (2015) Oncolytic Sendai virus-based virotherapy for cancer: recent advances. Oncolytic Virother 4:141\u2013147. https:\/\/doi.org\/10.2147\/OV.S66419","journal-title":"Oncolytic Virother"},{"key":"5172_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0304-3835(95)03692-p","volume":"90","author":"H S\u00f6nmez","year":"1995","unstructured":"S\u00f6nmez H, K\u00f6ko\u011flu E, Fau - S\u00fcer S, S\u00fcer S, Fau - Ozyurt E, Ozyurt E (1995) Fibronectin and Sialic acid levels in human meningiomas and gliomas. Cancer Lett 90:119\u2013122. https:\/\/doi.org\/10.1016\/0304-3835(95)03692-p","journal-title":"Cancer Lett"},{"key":"5172_CR39","doi-asserted-by":"publisher","unstructured":"Selke P, Bork K, Zhang T, Wuhrer M, Strauss C, Horstkorte R, Scheer M (2021) Glycation interferes with the expression of sialyltransferases in meningiomas. Cells 10. https:\/\/doi.org\/10.3390\/cells10123298","DOI":"10.3390\/cells10123298"},{"key":"5172_CR40","doi-asserted-by":"publisher","unstructured":"Cordova-Rivas S, Fraire-Soto I, Mercado-Casas Torres A, Servin-Gonzalez LS, Granados-Lopez AJ, Lopez-Hernandez Y, Reyes-Estrada CA, Gutierrez-Hernandez R, Castaneda-Delgado JE, Ramirez-Hernandez L, Varela-Silva JA, Lopez JA (2019) 5p and 3p strands of miR-34 family members have differential effects in cell proliferation, migration, and invasion in cervical Cancer cells. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/ijms20030545","DOI":"10.3390\/ijms20030545"},{"key":"5172_CR41","doi-asserted-by":"publisher","first-page":"e3100","DOI":"10.1038\/cddis.2017.495","volume":"8","author":"E Slabakova","year":"2017","unstructured":"Slabakova E, Culig Z, Remsik J, Soucek K (2017) Alternative mechanisms of miR-34a regulation in cancer. Cell Death Dis 8:e3100. https:\/\/doi.org\/10.1038\/cddis.2017.495","journal-title":"Cell Death Dis"},{"key":"5172_CR42","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/25141","volume":"396","author":"F Li","year":"1998","unstructured":"Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580\u2013584. https:\/\/doi.org\/10.1038\/25141","journal-title":"Nature"},{"key":"5172_CR43","doi-asserted-by":"publisher","first-page":"e0185217","DOI":"10.1371\/journal.pone.0185217","volume":"12","author":"TL Winther","year":"2017","unstructured":"Winther TL, Torp SH (2017) The anti-apoptotic protein survivin can improve the prognostication of meningioma patients. PLoS ONE 12:e0185217. https:\/\/doi.org\/10.1371\/journal.pone.0185217","journal-title":"PLoS ONE"},{"key":"5172_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/cbr.2018.2503","volume":"33","author":"Y Deng","year":"2018","unstructured":"Deng Y, Zhao F, Zhang Z, Sun F, Wang M (2018) Long noncoding RNA SNHG7 promotes the tumor growth and Epithelial-to-Mesenchymal transition via regulation of miR-34a signals in osteosarcoma. Cancer Biother Radiopharm 33:365\u2013372. https:\/\/doi.org\/10.1089\/cbr.2018.2503","journal-title":"Cancer Biother Radiopharm"},{"key":"5172_CR45","doi-asserted-by":"publisher","unstructured":"Mansoori B, Silvestris N, Mohammadi A, Khaze V, Baghbani E, Mokhtarzadeh A, Shanehbandi D, Derakhshani A, Duijf PHG, Baradaran B (2021) miR-34a and miR-200c have an additive Tumor-Suppressive effect on breast Cancer cells and patient prognosis. Genes (Basel) 12. https:\/\/doi.org\/10.3390\/genes12020267","DOI":"10.3390\/genes12020267"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05172-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05172-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05172-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:58:06Z","timestamp":1757487486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05172-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5172"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05172-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Tsukuba animal experiment committee approved the animal experiment (approved No. 23\u2013058).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}